Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
3 Dividend Stocks You Can Buy and Hold for Decades
09:52am, Friday, 13'th May 2022 The Motley Fool
You can really think long term with these great dividend stocks.
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals
06:47pm, Thursday, 12'th May 2022 Zacks Investment Research
AbbVie's (ABBV) Rinvoq achieves statistical significance with its co-primary endpoints of clinical remission and endoscopic response in a late-stage study for Crohn's disease.
Lilly's (LLY) Olumiant Gets Full Approval From FDA for COVID
12:02pm, Thursday, 12'th May 2022 Zacks Investment Research
The FDA grants full approval to Lilly (LLY) and Incyte for COVID-19 in certain hospitalized adults. Olumiant is already authorized for emergency use for this indication since November 2020.
The Zacks Analyst Blog Highlights AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings
11:52am, Wednesday, 11'th May 2022 Zacks Investment Research
AbbVie, Qualcomm, Linde, CVS Health Corp, and Booking Holdings are part of Zacks top Analyst Blog.
Should First Trust Morningstar Dividend Leaders ETF (FDL) Be on Your Investing Radar?
10:20am, Wednesday, 11'th May 2022 Zacks Investment Research
Style Box ETF report for FDL
2 Cash-Rich Dividend Stocks To Counter Growing U.S. Recession Risks
05:48am, Wednesday, 11'th May 2022 Investing.com
Q1 Earnings Scorecard and Analyst Reports for AbbVie, QUALCOMM & Linde
06:58pm, Tuesday, 10'th May 2022 Zacks Investment Research
Today's Research Daily features a real-time update on the Q1 earnings season and new research reports on AbbVie (ABBV), QUALCOMM (QCOM), and Linde(LIN).
Reata (RETA) Q1 Earnings Top, Omaveloxolone MAA Likely in Q4
02:45pm, Tuesday, 10'th May 2022 Zacks Investment Research
Reata (RETA) reports a narrower-than-expected loss for the first quarter of 2022 while revenues miss estimates.
AbbVie: Buy, Hold, Or Sell After Q1 Results?
01:00pm, Sunday, 08'th May 2022 Seeking Alpha
AbbVie stock was under heavy selling pressure following its Q1 ‘22 earnings. Check out whether ABBV stock is a buy, hold or sell after its Q1 earnings.
Fundamentals Of U.S. Stocks Dominating Major Indices Are More Important Than Ever
04:14pm, Friday, 06'th May 2022 Investing.com
Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues
02:24pm, Friday, 06'th May 2022 Zacks Investment Research
Ironwood (IRWD) witnesses strong year-over-year sales growth on continued demand for Linzess. Its first-quarter earnings miss estimates. The company maintains revenue guidance for 2022. Stock declines
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
01:00pm, Thursday, 05'th May 2022 Zacks Investment Research
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
3 Top Healthcare Stocks to Buy for May
12:15pm, Thursday, 05'th May 2022 The Motley Fool
These three stocks are leaders in their respective areas of the healthcare sector.
Pfizer Is Poised to Shatter These 2 Records in 2022
09:55am, Thursday, 05'th May 2022 The Motley Fool
The big drugmaker should be in store for a banner year on a couple of fronts.
This Stock Is Trouncing the Market in 2022 -- and Its Prospects Just Got Even Better
09:52am, Thursday, 05'th May 2022 The Motley Fool
The big biotech's winning ways are likely to continue.
